Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines Read more about Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines32 views
Seizures following vaccination in children: What you need to know and how to manage subsequent vaccinations Read more about Seizures following vaccination in children: What you need to know and how to manage subsequent vaccinations101 views
Australia needs a vaccine injury compensation scheme Read more about Australia needs a vaccine injury compensation scheme88 views
Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia Read more about Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia99 views
Adverse events following HPV vaccination: 11 years of surveillance in Australia Read more about Adverse events following HPV vaccination: 11 years of surveillance in Australia118 views
Developmental outcomes following vaccine-proximate febrile seizures in young children: a prospective case-control study Read more about Developmental outcomes following vaccine-proximate febrile seizures in young children: a prospective case-control study42 views
Active surveillance of acute pediatric hospitalisations demonstrates the impact of vaccination programs and informs vaccine policy in Canada and Australia Read more about Active surveillance of acute pediatric hospitalisations demonstrates the impact of vaccination programs and informs vaccine policy in Canada and Australia60 views
Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety Read more about Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety52 views
Case Series: Yellow fever vaccination in egg-allergic children Read more about Case Series: Yellow fever vaccination in egg-allergic children24 views
Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program Read more about Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program61 views
